Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-11

Clinical Trial Update: Exercise Treatment of Mild-Stage Probable Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated exercise treatment for individuals with mild-stage probable Alzheimer's disease; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Alzheimer Disease, Memory Disorders | Phase 2 | Status: COMPLETED